MNBTD
JAZZ icon

Moody National Bank Trust Division’s Jazz Pharmaceuticals JAZZ Stock Holding History

Moody National Bank Trust Division’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-279
Closed -$40K – 673
2019
Q1 		$40K Buy
+279
New +$36.4K ﹤0.01% 443

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Moody National Bank Trust Division's JAZZ Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 279 shares — an estimated $40K sold.

Moody National Bank Trust Division first reported a position in JAZZ in Q1 2019 and held it in 1 quarter. The position peaked at $40K in Q1 2019. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 279 Jazz Pharmaceuticals shares in Q2 2019, an estimated $40K.
  • Moody National Bank Trust Division first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Jazz Pharmaceuticals position peaked at $40K in Q1 2019.
  • 416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.